Hennessy Advisors Inc. reduced its holdings in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 8.9% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 177,500 shares of the company's stock after selling 17,300 shares during the quarter. Hennessy Advisors Inc. owned 0.09% of BrightSpring Health Services worth $10,073,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of BTSG. Allworth Financial LP bought a new stake in shares of BrightSpring Health Services in the 2nd quarter worth approximately $28,000. Root Financial Partners LLC purchased a new position in BrightSpring Health Services in the 3rd quarter worth $25,000. IFP Advisors Inc lifted its stake in BrightSpring Health Services by 204.5% in the second quarter. IFP Advisors Inc now owns 606 shares of the company's stock worth $42,000 after purchasing an additional 407 shares during the last quarter. Kilter Group LLC bought a new stake in BrightSpring Health Services in the second quarter worth $50,000. Finally, Public Employees Retirement System of Ohio purchased a new stake in BrightSpring Health Services during the second quarter valued at about $63,000.
Analyst Upgrades and Downgrades
BTSG has been the topic of several recent analyst reports. BMO Capital Markets restated an "outperform" rating on shares of BrightSpring Health Services in a report on Friday, October 2nd. Wells Fargo & Company upped their price objective on shares of BrightSpring Health Services from $61.00 to $78.00 and gave the company an "overweight" rating in a research note on Monday, July 13th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $70.00 target price on shares of BrightSpring Health Services in a report on Monday, August 3rd. Morgan Stanley upped their price target on BrightSpring Health Services from $71.00 to $80.00 and gave the company an "overweight" rating in a research report on Tuesday, July 14th. Finally, UBS Group increased their price objective on BrightSpring Health Services from $63.00 to $85.00 and gave the stock a "buy" rating in a report on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $72.88.
View Our Latest Stock Report on BTSG
Trending Headlines about BrightSpring Health Services
Here are the key news stories impacting BrightSpring Health Services this week:
- Positive Sentiment: Third-quarter earnings exceeded expectations. BrightSpring reported adjusted earnings of $0.54 per share, up from $0.30 a year earlier and above analyst estimates ranging from $0.47 to $0.49. This marked another quarterly earnings beat for the company. BrightSpring Q3 earnings and revenue results
- Positive Sentiment: Revenue growth was substantially stronger than forecast. Quarterly revenue rose 26.4% year over year to $4.21 billion, surpassing the $3.88 billion consensus estimate. The revenue performance indicates continued expansion across BrightSpring’s healthcare services platform. BrightSpring Q3 revenue report
- Positive Sentiment: Management increased full-year 2026 guidance. BrightSpring raised its revenue and adjusted EBITDA outlook, reinforcing investor confidence that operating momentum and profitability will remain strong. BrightSpring reports Q3 results and raises guidance
- Positive Sentiment: Profitability improved. BrightSpring posted a 16.73% return on equity and a 2.55% net margin, while the earnings beat and stronger revenue helped support the positive market reaction. BrightSpring bottom-line results
BrightSpring Health Services Stock Performance
NASDAQ:BTSG opened at $66.89 on Monday. The company's 50 day moving average price is $59.94 and its 200-day moving average price is $54.54. BrightSpring Health Services, Inc. has a 52 week low of $30.64 and a 52 week high of $73.75. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.99. The stock has a market cap of $13.23 billion, a price-to-earnings ratio of 36.16, a PEG ratio of 0.87 and a beta of 1.77.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last released its quarterly earnings data on Friday, October 30th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.47 by $0.07. BrightSpring Health Services had a return on equity of 18.56% and a net margin of 2.69%. The company had revenue of $4.21 billion during the quarter, compared to the consensus estimate of $3.88 billion. The firm's revenue was up 26.4% compared to the same quarter last year. On average, equities research analysts forecast that BrightSpring Health Services, Inc. will post 1.64 earnings per share for the current fiscal year.
BrightSpring Health Services Company Profile
(
Free Report)
BrightSpring Health Services NASDAQ: BTSG is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.
Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.
Featured Stories
Want to see what other hedge funds are holding BTSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.